Community/Retail

A patient at age 65 with high blood pressure could extend their life by more than a year with intensive treatment focused on a target systolic blood pressure of less than 120 mm Hg.

A team of researchers from Columbia University, New York City compared the incidence of chlamydia infection in adolescent LARC users to non-LARC users.

The Clinical Performance and Quality Measures included 6 performance measures, 6 process quality measures, and a new category of 10 structural quality measures for adults with high blood pressure.

Certain subgroups may see a greater reduction in heart failure hospitalizations and cardiovascular death with the combination of sacubitril and valsartan.

The 24-hour telehealth option is available 7 days a week to people with minor illnesses, minor injuries, and skin conditions.

Top news of the day from across the health care landscape.

The Community Pharmacy Foundation recently sponsored a study entitled, “Evaluation Of Enhanced Community Pharmacy Services.”

A recent study suggests that hyperkalemia and uncomplicated hyperglycemia in patients treated in the emergency department is commonly caused by iatrogenesis.

Officials from the FDA have approved MiSight 1-day contact lenses (CooperVision), a daily wear, single use contact lens indicated for the use of myopia management. This is the first FDA-approved product clinically proven to slow the progression of myopia, or near-sightedness, when initially prescribed for children ages 8-12 years.

Clinical data has illustrated how digital interventions can have a substantial material benefit on glycemic control in users with diabetes, with 73 of 162 users in the study reducing their average blood glucose levels to under 140 mg/dL.

Top news of the day from across the health care landscape.

Why is this woman in opioid withdrawal despite high dose methadone administration?

A newly-developed machine learning system may help act as an alert system for potential adverse effects from drug-drug interactions.

An analysis presented at the American Heart Association Annual Scientific Sessions showed that evolocumab (Repatha, Amgen) lowered the risk of cardiovascular events in patients who have recently had a heart attack.

cvMOBIUS will examine lipid management and the effectiveness of evolocumab (Repatha, Amgen) on cardiovascular outcomes.

Implementing more aggressive treatment plans from the American Heart Association’s 2017 guide were seen as more cost-effective over 10 years.

Top news of the day from across the health care landscape.

Cefiderocol (Fetroja, Shionogi) is indicated for adults with complicated urinary tract infections, including kidney infections caused by Gram-negative pathogens, who have limited or no alternative treatment options.

Cenobamate is an investigational antiepileptic drug that has shown broad spectrum anticonvulsant activity in preclinical studies and seizure models.

Centers for Disease Control and Prevention warns the time for action is now in the "post-antibiotic era."

Receiving a flu shot before a heart bypass surgery can stop inflammation throughout the body and possibly lead to a healthier recovery, according to a preliminary study presented at the American Heart Association’s Scientific Sessions in Philadelphia, Pennsylvania.

Alirocumab, a proprotein convertase subtilisin/kexin type 9 inhibitor, was compared with a placebo in patients with ACS and persistent dyslipidemia, in addition to receiving treatment with high-intensity or maximum tolerated statin therapy.

Neither vitamin D nor omega-3 fatty acid supplementation were found to significantly inhibit changes in serum creatinine and cystatin C decline over 5 years among adults with type 2 diabetes.

The online resource features CBD products that have been tested for concentrations of all cannabinoids, including CBD and tetrahydrocannabinol (THC), by an independent, third-party lab, as well as experts that pharmacists can contact with questions regarding buying, selling, and marketing.

The injectable hormone tesamorelin was found to reduce liver fat and prevent liver fibrosis or scarring in people living with HIV, according to researchers and the National Institutes of Health and the National Institute of Allergy and Infectious Disease (NIAD).

A recent study published in CANCER indicates that for patients with both HIV and cancer, implementation of the Patient Protection and Affordable Care Act (ACA) improved insurance coverage, both in states that expanded Medicaid coverage and in states that did not.1

InsightRx, a company specializing in precision medicine, and Premier Inc, a health care improvement company, have partnered to individualize medication dosing for drugs used to treat infectious diseases.

Top news of the day from across the health care landscape.

Roxadustat for the treatment of patients with anemia from chronic kidney disease was shown to have positive efficacy and no increased cardiovascular risk in patients dependent and not dependent on dialysis.

What is causing a positive drug test in a patient that only takes blood pressure medications?